$Nuvation Bio (NUVB.US)$ NEWS Nuvation Bio Completes Acquisi...
NEWS
Nuvation Bio Completes Acquisition of AnHeart Therapeutics
Nuvation Bio completes the acquisition of AnHeart Therapeutics, transforming into a late-stage global oncology company. Shareholders now own approximately 67% and 33% of NUVB, setting the stage for potential commercial success by 2025.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment